A drug therapy for epilepsy and shingles pain is being voluntarily recalled by its manufacturer due to complaints of empty capsules. The empty capsules of gabapentin could result in a reduction in efficacy, short-term withdrawal, or long-period seizures, which could be life-threatening, according to an FDA MedWatch alert.
Aurobindo Pharma USA announced it would recall lot GESB14011-A of gabapentin capsules, USP 300 mg 100-count bottles because of the error. The bottles have an expiration date of December 2015 and were distributed through the Northstar label to retail outlets across the nation.
The Epilepsy Network is a worldwide community of people with epilepsy, family and friends, uniting to talk about their experiences, learn information about epilepsy, ask questions and so much more! Don’t let epilepsy defeat you, let it inspire you!
